Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anteris Technologies (AMEUF)
OTHER OTC:AMEUF
Anteris Technologies (AMEUF) Stock Price & Analysis
5 Followers
AMEUF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$10.28 - $15.95
Previous Close$15.03
Volume100.00
Average Volume (3M)919.00
Market Cap
$289.55M
Enterprise Value$306.61B
Total Cash (Recent Filing)AU$14.40B
Total Debt (Recent Filing)AU$222.58B
Price to Earnings (P/E)-5.3
Beta1.18
Next Earnings
Aug 23, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.86
Shares Outstanding15,422,552
10 Day Avg. Volume11
30 Day Avg. Volume919
Standard Deviation5.44
R-Squared0.11
Alpha1.19
Financial Highlights & Ratios
Price to Book (P/B)27.98
Price to Sales (P/S)65.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-143.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Anteris Technologies News
PremiumCompany Announcements
Anteris Technologies Secures $24M in Share Issue
PremiumCompany Announcements
Anteris Tech Advances Heart Valve, Eyes NASDAQ
PremiumCompany Announcements
Anteris Technologies Seeks New Security Quotations
PremiumCompany Announcements
Anteris Technologies Applies for New Share Quotation
PremiumCompany Announcements
Anteris Technologies Strengthens Corporate Governance
PremiumCompany Announcements
Anteris Technologies Seeks New Stock Quotation
PremiumCompany Announcements
Anteris Technologies Shareholder Voting Power Shifts
PremiumCompany Announcements
Anteris Technologies Sets Date for AGMAMEUF FAQ
What was Anteris Technologies’s price range in the past 12 months?
Anteris Technologies lowest stock price was $10.28 and its highest was $15.95 in the past 12 months.
What is Anteris Technologies’s market cap?
Currently, no data Available
When is Anteris Technologies’s upcoming earnings report date?
Anteris Technologies’s upcoming earnings report date is Aug 23, 2024 which is in 120 days.
How were Anteris Technologies’s earnings last quarter?
Anteris Technologies released its earnings results on Feb 28, 2024. The company reported -$1.476 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.476.
Is Anteris Technologies overvalued?
According to Wall Street analysts Anteris Technologies’s price is currently Overvalued.
Does Anteris Technologies pay dividends?
Anteris Technologies does not currently pay dividends.
What is Anteris Technologies’s EPS estimate?
Anteris Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anteris Technologies have?
Anteris Technologies has 19,210,316 shares outstanding.
What happened to Anteris Technologies’s price movement after its last earnings report?
Anteris Technologies reported an EPS of -$1.476 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.088%.
Which hedge fund is a major shareholder of Anteris Technologies?
Currently, no hedge funds are holding shares in AMEUF
---
Anteris Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-2.43%
12-Months-Change
Fundamentals
Return on Equity
-313.42%
Trailing 12-Months
Asset Growth
95.85%
Trailing 12-Months
Company Description
Anteris Technologies
Admedus Ltd is an Australia-based healthcare company which develops, commercializes and distributes next-generation medical technologies and devices. It is engaged in the sale and distribution of the infusion medical device and the ADAPT tissue portfolio with a particular focus in the area of cardiovascular Neonatal repair. The business activity of the company is operated through four segment namely Disposable medical product and medical devices distribution; Bio implant operations - inclusive of sales, distribution, and manufacturing; Regenerative medicine R&D-ADAPT technology, and Immunotherapies research and development.
---
Technical Analysis
Alphatec Holdings
―
Atossa Therapeutics
―
Anthera Pharmaceuticals
―
Hai Jia International Limited
―
Best Analysts Covering AMEUF
1 Year
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
initiated a buy rating 5 months ago
Copying Peter Niu's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
---